Process Intensification: ROI Realities & Implementation Considerations

Susan Dexter, CTO at Sonnet Biotherapeutics and process intensification pioneer Parrish Galliher discuss cost reduction and ROI realities associated with process intensification in this segment of the Bioprocess Online Live event “Upstream Process Intensification In Practice.” They suggest that the ROI on process intensification initiatives are ultimately dependent on your ability to increase yield, cover the key metrics and performance indicators necessary to measure those outcomes, and walk us through the role of single use technology and common implementation challenges.